CFA Pharma
ActiveSummary
CFA Pharma has been active since 1986 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €153,937 and a net result of €6,743. Equity is growing by about 2.8% per year across the filed financial years. Its solvency ranks better than 46% of 22,595 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.6% (low).
Articles of association
What the company does
- Name clauseThe name the company operates under according to its articles.
- CFA Pharma
Who represents it, and how
- Board ruleHow the board is made up, meets and takes decisions.
- “Bepaalde of onbepaalde duur, onbepaalde duur bij gebrek aan bepaling van de duurtijd” (deed in Dutch)
Meetings and financial year
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- Third Saturday of June at 19:00